School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Biotechnol Appl Biochem. 2021 Aug;68(4):695-699. doi: 10.1002/bab.2033. Epub 2020 Oct 19.
According to the evidence, the coronavirus disease 19 (COVID-19) is caused by a zoonotic pathogen named respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus can spread through personal contact, respiratory droplets, and also through airborne transmission. A rapid, low-cost, and effective biosensor platform is essential to diagnose patients with COVID-19 infection, predominantly the asymptomatic individuals, and prevent the spread of the SARS-CoV-2 via transmission routes. The objective of this review is to provide a comparative view among current diagnostic methods, focusing on recently suggested biosensors for the detection of SARS-CoV2 in clinical samples. A capable SARS-CoV-2 biosensor can be designed by the holistic insights of various biosensor studies.
根据证据,2019 年冠状病毒病(COVID-19)是由一种名为严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的人畜共患病原体引起的。这种病毒可以通过人际接触、呼吸道飞沫传播,也可以通过空气传播。一个快速、低成本和有效的生物传感器平台对于诊断 COVID-19 感染患者,主要是无症状个体,以及通过传播途径预防 SARS-CoV-2 的传播至关重要。本综述的目的是提供当前诊断方法的比较观点,重点介绍最近提出的用于检测临床样本中 SARS-CoV2 的生物传感器。通过对各种生物传感器研究的整体了解,可以设计出一种有能力的 SARS-CoV-2 生物传感器。